We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$685M
2
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$54.5M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$42.1M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$27.7M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Financials 11.47%
3 Healthcare 11.18%
4 Consumer Discretionary 10.98%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIOT
3976
PowerFleet Inc
AIOT
$421M
$18K ﹤0.01%
2,204
-1,593
-42% -$13.1K
GPUS
3977
Hyperscale Data Inc
GPUS
$52.2M
– –
0
– –
CALB
3978
DELISTED
California BanCorp Common Stock
CALB
$18K ﹤0.01%
1,023
-1,235
-55% -$19.9K
LBC
3979
DELISTED
Luther Burbank Corporation Common Stock
LBC
$18K ﹤0.01%
1,492
-6,419
-81% -$68.8K
CS
3980
DELISTED
Credit Suisse Group
CS
$18K ﹤0.01%
1,700
-14,867
-90% -$201K
OYST
3981
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$18K ﹤0.01%
959
-2,521
-72% -$52.9K
PCSB
3982
DELISTED
PCSB Financial Corporation
PCSB
$18K ﹤0.01%
1,067
-2,354
-69% -$38.6K
RBAC.U
3983
DELISTED
RedBall Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one
RBAC.U
$18K ﹤0.01%
1,815
+753
+71% +$8.38K
SBBP
3984
DELISTED
Strongbridge Biopharma plc.
SBBP
$18K ﹤0.01%
6,482
-6,542
-50% -$19.7K
ARD
3985
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$18K ﹤0.01%
696
-9,872
-93% -$213K
STND
3986
DELISTED
Standard AVB Financial Corp. Common Stock
STND
$18K ﹤0.01%
552
-1,170
-68% -$38.3K
UBA
3987
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$18K ﹤0.01%
1,054
-32,058
-97% -$504K
ABEO icon
3988
Abeona Therapeutics
ABEO
$361M
$17K ﹤0.01%
358
-387
-52% -$21.3K
ACRS icon
3989
Aclaris Therapeutics
ACRS
$863M
$17K ﹤0.01%
691
+418
+153% +$8.17K
ACWX icon
3990
iShares MSCI ACWI ex US ETF
ACWX
$12B
$17K ﹤0.01%
306
-184
-38% -$10.2K
ASPN icon
3991
Aspen Aerogels
ASPN
$504M
$17K ﹤0.01%
818
-7,918
-91% -$167K
AUTL
3992
Autolus Therapeutics
AUTL
$591M
$17K ﹤0.01%
3,080
+1,468
+91% +$10.9K
BTBT icon
3993
Bit Digital
BTBT
$520M
$17K ﹤0.01%
+1,130
New +$20.9K
CARE icon
3994
Carter Bankshares
CARE
$757M
$17K ﹤0.01%
1,212
-5,596
-82% -$67.9K
CDZI icon
3995
Cadiz
CDZI
$295M
$17K ﹤0.01%
1,746
-2,090
-54% -$22.4K
CMBM
3996
DELISTED
Cambium Networks
CMBM
$17K ﹤0.01%
360
-1,371
-79% -$54.4K
CPHC icon
3997
Canterbury Park Holding Corp
CPHC
$81.4M
$17K ﹤0.01%
1,241
+103
+9% +$1.38K
CPSS icon
3998
Consumer Portfolio Services
CPSS
$208M
$17K ﹤0.01%
4,237
-2,692
-39% -$11.6K
DBE icon
3999
Invesco DB Energy Fund
DBE
$90.5M
$17K ﹤0.01%
1,267
+920
+265% +$11.6K
DRVN icon
4000
Driven Brands
DRVN
$2.12B
$17K ﹤0.01%
+675
New +$19.1K
158 159
160
161 162

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.